Abstracts

MEMORY NK CELLS AS NOVEL EFFECTORS AGAINST HIV AND SIV

Natural killer (NK) cells provide rapid early responses to viral infections and thus can contribute substantially to disease modulation and potentially vaccine efficacy. Traditionally, NK cells have been considered to be nonspecific components of innate immunity, but burgeoning evidence suggests that the functional repertoire of NK cells is far more diverse and can include adaptive…

HIV SUPPRESSION BY CD8+ LYMPHOCYTES

The persistence of HIV infection under ART is due to a reservoir of latently infected cells that remain indefinitely despite full suppression of virus replication. HIV latency is triggered by several mechanisms that lead to the silencing of virus expression including epigenetic DNA modification through methylation and histone deacetylation, limited availability of critical transcription factors…

OBESITY: A GROWING PROBLEM IN ANTIRETROVIRAL THERAPY

Over the past two decades, the prevalence of obesity (i.e., body mass index ≥30kg/m2) among persons living with HIV (PLWH) has steadily risen, which is clinically important as obesity increases the risk of diabetes, cardiovascular disease, fatty liver disease, neurocognitive impairment, and other comorbidities. Among PLWH, traditional risk factors for obesity (e.g., food insecurity, lack…

I KEEP FORGETTING: HIV, AGING, AND COGNITIVE DISORDERS

HIV infection is a leading cause of cognitive impairment in people under the age of 60, worldwide. Historically, there was little need to differentiate cognitive disorders due to HIV from that of age-associated neurodegenerative disorders, such as Alzheimer’s disease, because few patients living with HIV survived into geriatric age groups where prevalence of these neurodegenerative…

PrEP FAILURES: DIAGNOSIS, RESISTANCE, AND TREATMENT

PrEP with TDF/FTC has shown in demonstration projects and real life implementation an effectiveness that was better than in clinical trials. However, despite its high effectiveness, and because of its increased use, a number of PrEP failures have been reported highlighting that, as any preventive tool, only proper use will be associated with protection against…

CAN TWO DRUGS TANGO: THE ROLE OF DUAL THERAPY

In an era of largely well-tolerated antiretrovirals with high virological efficacy, the new ‘battle’ is that of two vs three drug regimens (2DR vs 3DR). The majority of studied 2DR have been boosted-protease inhibitor based so, despite any possible benefit of fewer drugs, hampered by the limitations of the PI class including tolerability, long-term toxicity…

YOUNG TRANSGENDER INDIVIDUALS

Transgender and gender diverse youth (i.e., those whose gender identity does not align with their sex assigned at birth), especially transfeminine youth of color, face high rates of verbal and physical violence, unsafe school environments, family rejection and homelessness. Stigma and discrimination against transgender people have been linked to adverse health outcomes, such as low…

ENGAGING YOUNG WOMEN IN SUB-SAHARAN AFRICA

Adolescent girls and young women (AGYW) in sub-Saharan Africa (SSA) are at substantial risk for HIV infection. Oral PrEP has the potential to provide HIV protection if used consistently. Two blinded efficacy trials of oral PrEP in women in SSA did not show evidence of HIV protection in AGYW because of low adherence in these…